ArticleJournal of thoracic disease2025

Prediction of the efficacy and clinical prognosis of first-line EGFR-tyrosine kinase inhibitors in non-small cell lung cancer patients based on ΔCt values derived from the super-amplification refractory mutation system (ARMS): a real-world retrospective study.

Zhuohao Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.